Iridex reaffirms FY2026 sales guidance at $51M–$53M
Iridex (NASDAQ: IRIX) affirms FY2026 sales outlook of $51.000M–$53.000M versus a $53.227M estimate, keeping guidance unchanged in the stated range.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.